ABVX: Abivax Sa Financial Statements
Balance sheet, income statement, and cash flow statements for Abivax Sa (ABVX).
$460.67M Market Cap.
ABVX Market Cap. (MRY)
ABVX Shares Outstanding (MRY)
ABVX Assets (MRY)
Total Assets
$205.23M
Total Liabilities
$164.64M
Total Investments
$13.47M
ABVX Income (MRY)
Revenue
$12.45M
Net Income
-$176.24M
Operating Expense
$185.43M
ABVX Cash Flow (MRY)
CF Operations
-$154.07M
CF Investing
$15.76M
CF Financing
$28.21M
ABVX Balance Sheet (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total Assets | $205,228,000 (-37.25%) | $327,062,000 (332.94%) | $75,544,000 (-30.84%) | $109,230,000 |
Assets Current | $170,671,000 (-40.32%) | $285,972,000 (690.39%) | $36,181,000 (-52.07%) | $75,485,000 |
Assets Non-Current | $34,557,000 (-15.90%) | $41,090,000 (4.39%) | $39,363,000 (16.65%) | $33,745,000 |
Goodwill & Intangible Assets | $25,025,000 (0.01%) | $25,023,000 (-0.01%) | $25,026,000 (-22.03%) | $32,098,000 |
Shareholders Equity | $40,584,000 (-79.29%) | $196,010,000 (2626.53%) | $7,189,000 (-72.28%) | $25,934,000 |
Property Plant & Equipment Net | $2,666,000 (203.64%) | $878,000 (-44.85%) | $1,592,000 (421.97%) | $305,000 |
Cash & Equivalents | $144,221,000 (-42.76%) | $251,942,000 (834.85%) | $26,950,000 (-55.60%) | $60,701,000 |
Accumulated Other Comprehensive Income | -$75,000 (-166.96%) | $112,000 (0%) | $0 (0%) | $0 |
Deferred Revenue | $0 (0%) | $52,000 (-60.90%) | $133,000 (-17.90%) | $162,000 |
Total Investments | $13,473,000 (-38.91%) | $22,056,000 (88.38%) | $11,708,000 (772.43%) | $1,342,000 |
Investments Current | $7,554,000 (-17.77%) | $9,186,000 (0%) | $0 (0%) | $0 |
Investments Non-Current | $5,919,000 (-54.01%) | $12,870,000 (9.92%) | $11,708,000 (772.43%) | $1,342,000 |
Inventory | $0 (0%) | $0 (0%) | $0 (0%) | $0 |
Trade & Non-Trade Receivables | $0 (0%) | $0 (0%) | $0 (0%) | $0 |
Trade & Non-Trade Payables | $43,824,000 (-7.19%) | $47,221,000 (205.14%) | $15,475,000 (-16.61%) | $18,558,000 |
Accumulated Retained Earnings (Deficit) | -$438,879,000 (-55.11%) | -$282,949,000 (-97.16%) | -$143,510,000 (-75.41%) | -$81,813,000 |
Tax Assets | $0 (0%) | $0 (0%) | $0 (0%) | $0 |
Tax Liabilities | $4,709,000 (-22.46%) | $6,073,000 (164.04%) | $2,300,000 (4.55%) | $2,200,000 |
Total Debt | $109,218,000 (46.67%) | $74,466,000 (51.26%) | $49,231,000 (-4.69%) | $51,653,000 |
Debt Current | $43,769,000 (25.89%) | $34,769,000 (3.62%) | $33,555,000 (195.77%) | $11,345,000 |
Debt Non-Current | $65,449,000 (64.87%) | $39,697,000 (153.23%) | $15,676,000 (-61.11%) | $40,308,000 |
Total Liabilities | $164,644,000 (25.63%) | $131,052,000 (91.72%) | $68,355,000 (-17.94%) | $83,296,000 |
Liabilities Current | $93,999,000 (3.64%) | $90,695,000 (76.23%) | $51,464,000 (59.50%) | $32,265,000 |
Liabilities Non-Current | $70,645,000 (75.05%) | $40,357,000 (138.93%) | $16,891,000 (-66.90%) | $51,031,000 |
ABVX Income Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Revenues | $12,449,000 (169.40%) | $4,621,000 (0.83%) | $4,583,000 (-61.68%) | $11,961,000 |
Cost of Revenue | $0 (0%) | $0 (0%) | $0 (0%) | $0 |
Selling General & Administrative Expense | $38,900,000 (34.97%) | $28,821,000 (284.69%) | $7,492,000 (34.27%) | $5,580,000 |
Research & Development Expense | $146,532,000 (42.02%) | $103,176,000 (113.64%) | $48,295,000 (1.08%) | $47,781,000 |
Operating Expenses | $185,432,000 (40.48%) | $131,997,000 (90.15%) | $69,419,000 (30.09%) | $53,361,000 |
Interest Expense | $16,991,000 (-39.05%) | $27,875,000 (296.97%) | $7,022,000 (97.19%) | $3,561,000 |
Income Tax Expense | $0 (0%) | $0 (0%) | $0 (0%) | $0 |
Net Loss Income from Discontinued Operations | $0 (0%) | $0 (0%) | $0 (0%) | $0 |
Consolidated Income | -$176,242,000 (-19.29%) | -$147,740,000 (-143.23%) | -$60,740,000 (-43.08%) | -$42,452,000 |
Net Income to Non-Controlling Interests | $0 (0%) | $0 (0%) | $0 (0%) | $0 |
Net Income | -$176,242,000 (-19.29%) | -$147,740,000 (-143.23%) | -$60,740,000 (-43.08%) | -$42,452,000 |
Preferred Dividends Income Statement Impact | $0 (0%) | $0 (0%) | $0 (0%) | $0 |
Net Income Common Stock | -$176,242,000 (-19.29%) | -$147,740,000 (-143.23%) | -$60,740,000 (-43.08%) | -$42,452,000 |
Weighted Average Shares | $63,046,350 (46.39%) | $43,066,012 (125.57%) | $19,092,442 (23.53%) | $15,455,991 |
Weighted Average Shares Diluted | $63,046,350 (46.39%) | $43,066,012 (125.57%) | $19,092,442 (23.53%) | $15,455,991 |
Earning Before Interest & Taxes (EBIT) | -$159,251,000 (-32.86%) | -$119,865,000 (-123.14%) | -$53,718,000 (-38.12%) | -$38,891,000 |
Gross Profit | $12,449,000 (169.40%) | $4,621,000 (0.83%) | $4,583,000 (-61.68%) | $11,961,000 |
Operating Income | -$172,983,000 (-35.81%) | -$127,376,000 (-96.46%) | -$64,836,000 (-56.61%) | -$41,400,000 |
ABVX Cash Flow Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Net Cash Flow from Investing | $15,762,000 (294.71%) | -$8,095,000 (32.69%) | -$12,026,000 (-92.97%) | -$6,232,000 |
Net Cash Flow from Financing | $28,207,000 (-91.59%) | $335,290,000 (940.92%) | $32,211,000 (-61.04%) | $82,679,000 |
Net Cash Flow from Operations | -$154,072,000 (-58.62%) | -$97,130,000 (-80.08%) | -$53,936,000 (-19.73%) | -$45,048,000 |
Net Cash Flow / Change in Cash & Cash Equivalents | -$107,720,000 (-147.88%) | $224,992,000 (766.62%) | -$33,751,000 (-207.49%) | $31,399,000 |
Net Cash Flow - Business Acquisitions and Disposals | -$231,000 (85.74%) | -$1,620,000 (86.27%) | -$11,798,000 (-91.03%) | -$6,176,000 |
Net Cash Flow - Investment Acquisitions and Disposals | $8,459,000 (198.25%) | -$8,610,000 (-11428.95%) | $76,000 (944.44%) | -$9,000 |
Capital Expenditure | -$643,000 (-142.64%) | -$265,000 (17.96%) | -$323,000 (-587.23%) | -$47,000 |
Issuance (Repayment) of Debt Securities | $34,778,000 (129.88%) | $15,129,000 (320.22%) | -$6,870,000 (-136.05%) | $19,057,000 |
Issuance (Purchase) of Equity Shares | $434,000 (-99.88%) | $353,387,000 (662.04%) | $46,374,000 (-33.45%) | $69,683,000 |
Payment of Dividends & Other Cash Distributions | $0 (0%) | $0 (0%) | $0 (0%) | $0 |
Effect of Exchange Rate Changes on Cash | $2,382,000 (146.96%) | -$5,072,000 (0%) | $0 (0%) | $0 |
Share Based Compensation | $20,224,000 (147.27%) | $8,179,000 (802.66%) | -$1,164,000 (-240.58%) | $828,000 |
Depreciation Amortization & Accretion | $1,100,000 (55.59%) | $707,000 (45.77%) | $485,000 (60.60%) | $302,000 |
ABVX Financial Metrics (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Gross Margin | 100.00% (0.00%) | 100.00% (0.00%) | 100.00% (0.00%) | 100.00% |
Profit Margin | -1415.70% (55.72%) | -3197.10% (-141.24%) | -1325.30% (-273.43%) | -354.90% |
EBITDA Margin | -1270.40% (50.73%) | -2578.60% (-122.01%) | -1161.50% (-260.04%) | -322.60% |
Return on Average Equity (ROAE) | -149.00% (-2.48%) | -145.40% (60.36%) | -366.80% | - |
Return on Average Assets (ROAA) | -66.20% (9.81%) | -73.40% (-11.72%) | -65.70% | - |
Return on Sales (ROS) | -1279.20% (50.68%) | -2593.90% (-121.30%) | -1172.10% (-260.54%) | -325.10% |
Return on Invested Capital (ROIC) | -374.40% (13.79%) | -434.30% (-131.01%) | -188.00% | - |
Dividend Yield | 0% (0%) | 0% | - | - |
Price to Earnings Ratio (P/E) | -2.51 (10.61%) | -2.81 | - | - |
Price to Sales Ratio (P/S) | 35.59 (-60.35%) | 89.75 | - | - |
Price to Book Ratio (P/B) | 10.9 (252.77%) | 3.09 | - | - |
Debt to Equity Ratio (D/E) | 4.06 (506.43%) | 0.67 (-92.96%) | 9.51 (196.01%) | 3.21 |
Earnings Per Share (EPS) | -2.8 (18.37%) | -3.43 (-7.86%) | -3.18 (-15.64%) | -2.75 |
Sales Per Share (SPS) | 0.21 (73.11%) | 0.12 (-53.33%) | 0.26 (-70.99%) | 0.88 |
Free Cash Flow Per Share (FCFPS) | -2.45 (-8.49%) | -2.26 (20.41%) | -2.84 (2.60%) | -2.92 |
Book Value Per Share (BVPS) | 0.64 (-85.85%) | 4.55 (1107.16%) | 0.38 (-77.53%) | 1.68 |
Tangible Assets Book Value Per Share (TABVPS) | 2.86 (-59.25%) | 7.01 (165.04%) | 2.65 (-46.97%) | 4.99 |
Enterprise Value Over EBIT (EV/EBIT) | -2 (60.00%) | -5 | - | - |
Enterprise Value Over EBITDA (EV/EBITDA) | -2.07 (54.86%) | -4.59 | - | - |
Asset Turnover | 0.05 (104.35%) | 0.02 (-54.00%) | 0.05 | - |
Current Ratio | 1.82 (-42.40%) | 3.15 (348.51%) | 0.7 (-69.96%) | 2.34 |
Dividends | $0 (0%) | $0 (0%) | $0 (0%) | $0 |
Free Cash Flow (FCF) | -$154,715,000 (-58.85%) | -$97,395,000 (-79.50%) | -$54,259,000 (-20.32%) | -$45,095,000 |
Enterprise Value (EV) | $340,937,459 (-43.85%) | $607,169,196 | - | - |
Earnings Before Tax (EBT) | -$176,242,000 (-19.29%) | -$147,740,000 (-143.23%) | -$60,740,000 (-43.08%) | -$42,452,000 |
Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | -$158,151,000 (-32.72%) | -$119,158,000 (-123.84%) | -$53,233,000 (-37.95%) | -$38,589,000 |
Invested Capital | $51,201,000 (51.18%) | $33,868,000 (58.74%) | $21,335,000 (-40.44%) | $35,819,000 |
Working Capital | $76,672,000 (-60.74%) | $195,277,000 (1377.74%) | -$15,283,000 (-135.36%) | $43,220,000 |
Tangible Asset Value | $180,203,000 (-40.34%) | $302,039,000 (497.88%) | $50,518,000 (-34.50%) | $77,132,000 |
Market Capitalization | $460,668,228 (-31.52%) | $672,741,828 | - | - |
Average Equity | $118,297,000 (16.43%) | $101,599,500 (513.47%) | $16,561,500 | - |
Average Assets | $266,145,000 (32.21%) | $201,303,000 (117.89%) | $92,387,000 | - |
Invested Capital Average | $42,534,500 (54.10%) | $27,601,500 (-3.41%) | $28,577,000 | - |
Shares | 62,932,818 (0.10%) | 62,873,068 (47.77%) | 42,547,568 | - |
